Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · Real-Time Price · USD

460.82

-17.07 (-3.57%)

At close: Mar 5, 2026, 4:00 PM EST

460.56

-0.26 (-0.06%)

Pre-market: Mar 6, 2026, 6:40 AM EST

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of $117.06 billion as of March 6, 2026. Its market cap has decreased by -3.37% in one year.

Market Cap

117.06B

Enterprise Value

106.78B

1-Year Change

-3.37%

Ranking

#132

Market Cap Chart

Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $117.06B, an increase of 19,043.75%. That is a compound annual growth rate of 21.24%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	117.06B	1.77%
Dec 31, 2025	115.03B	10.91%
Dec 31, 2024	103.71B	-1.09%
Dec 29, 2023	104.85B	41.44%
Dec 30, 2022	74.13B	32.76%
Dec 31, 2021	55.83B	-9.15%
Dec 31, 2020	61.46B	9.15%
Dec 31, 2019	56.30B	32.95%
Dec 31, 2018	42.35B	11.74%
Dec 29, 2017	37.90B	107.41%
Dec 30, 2016	18.27B	-40.90%
Dec 31, 2015	30.92B	8.21%
Dec 31, 2014	28.57B	64.52%
Dec 31, 2013	17.37B	91.17%
Dec 31, 2012	9.09B	31.16%
Dec 30, 2011	6.93B	-2.69%
Dec 31, 2010	7.12B	-8.32%
Dec 31, 2009	7.76B	69.85%
Dec 31, 2008	4.57B	48.74%
Dec 31, 2007	3.07B	-34.61%
Dec 29, 2006	4.70B	71.34%
Dec 30, 2005	2.74B	223.10%
Dec 31, 2004	848.90M	5.56%
Dec 31, 2003	804.20M	-33.56%
Dec 31, 2002	1.21B	-34.33%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Regeneron Pharmaceuticals	80.81B
argenx SE	45.72B
Alnylam Pharmaceuticals	43.41B
BeOne Medicines AG	33.17B
Insmed	32.31B
Royalty Pharma	27.36B
BioNTech SE	26.05B
Moderna	22.83B

Market Cap Rankings